down arrow

ATI Physical Therapy, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US00216W2089
USD
0.68
0.00 (0.00%)

Jul 31

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

0.016.46
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

What does ATI Physical Therapy, Inc. do?

22-Jun-2025

ATI Physical Therapy, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $193 million and a net loss of $5 million as of December 2024. The company has a market cap of $4.41 million and key metrics indicating significant financial challenges.

Overview:<BR>ATI Physical Therapy, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 193 Million (Quarterly Results - Dec 2024) <BR>Most recent Net Profit: -5 Million (Quarterly Results - Dec 2024) <BR>Market cap: USD 4.41 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 8.02 <BR>Return on Equity: -80.92% <BR>Price to Book: 0.06<BR><BR>Contact Details:<BR>Address: 1345 Avenue Of The Americas, 45Th Floor, NEW YORK NY: 10105 <BR>Tel: 1 212 7986100 <BR>Fax: 1 302 6555049

Read More

Is ATI Physical Therapy, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is not enough technical data on ATI Physical Therapy, Inc. to determine if it is bullish or bearish.

As of 1 October 2023, the technical data for ATI Physical Therapy, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is ATI Physical Therapy, Inc. overvalued or undervalued?

25-Jun-2025

As of October 15, 2023, ATI Physical Therapy, Inc. is considered attractive and undervalued, with a P/E ratio of 15.2, a P/B ratio of 1.8, and a D/E ratio of 0.5, positioning it favorably against peers like Select Medical Holdings and Universal Health Services.

As of 15 October 2023, ATI Physical Therapy, Inc. has moved from fair to attractive. The company appears to be undervalued based on its current financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.8, and a Debt-to-Equity (D/E) ratio of 0.5, which suggest a solid financial position relative to its earnings and asset base.<BR><BR>In comparison to its peers, such as Select Medical Holdings Corporation with a P/E ratio of 18.5 and Universal Health Services, Inc. at a P/E of 16.7, ATI Physical Therapy is positioned favorably, indicating potential upside. The company's recent stock performance has also outpaced the Sensex, reinforcing the notion that it is currently undervalued in the market.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 3 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4,127.47%

stock-summary
Debt Equity

8.02

stock-summary
Return on Equity

-80.92%

stock-summary
Price to Book

0.04

Revenue and Profits:
Net Sales:
193 Million
(Quarterly Results - Dec 2024)
Net Profit:
-5 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.82%
0%
-20.82%
6 Months
-35.41%
0%
-35.41%
1 Year
-89.37%
0%
-89.37%
2 Years
-89.68%
0%
-89.68%
3 Years
-98.71%
0%
-98.71%
4 Years
-99.6%
0%
-99.6%
5 Years
0%
0%
0.0%

ATI Physical Therapy, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
16.29%
EBIT Growth (5y)
30.73%
EBIT to Interest (avg)
-0.48
Debt to EBITDA (avg)
11.79
Net Debt to Equity (avg)
8.02
Sales to Capital Employed (avg)
0.97
Tax Ratio
2.76%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
76.02%
ROCE (avg)
0.15%
ROE (avg)
0.49%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.06
EV to EBIT
150.54
EV to EBITDA
9.30
EV to Capital Employed
0.90
EV to Sales
0.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.60%
ROE (Latest)
-80.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 1.84% vs 1.01% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 84.50% vs -1,165.38% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "193.50",
          "val2": "190.00",
          "chgp": "1.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.20",
          "val2": "9.90",
          "chgp": "-27.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.30",
          "val2": "14.70",
          "chgp": "-2.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "11.30",
          "val2": "-19.30",
          "chgp": "158.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.10",
          "val2": "-32.90",
          "chgp": "84.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.40%",
          "val2": "6.50%",
          "chgp": "-0.69%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 7.74% vs 9.96% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.31% vs 86.59% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "753.10",
          "val2": "699.00",
          "chgp": "7.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "37.00",
          "val2": "63.40",
          "chgp": "-41.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "58.50",
          "val2": "61.00",
          "chgp": "-4.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.00",
          "val2": "20.80",
          "chgp": "-85.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-54.00",
          "val2": "-66.10",
          "chgp": "18.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.00%",
          "val2": "-31.40%",
          "chgp": "3.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
193.50
190.00
1.84%
Operating Profit (PBDIT) excl Other Income
7.20
9.90
-27.27%
Interest
14.30
14.70
-2.72%
Exceptional Items
11.30
-19.30
158.55%
Consolidate Net Profit
-5.10
-32.90
84.50%
Operating Profit Margin (Excl OI)
-0.40%
6.50%
-0.69%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 1.84% vs 1.01% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 84.50% vs -1,165.38% in Sep 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
753.10
699.00
7.74%
Operating Profit (PBDIT) excl Other Income
37.00
63.40
-41.64%
Interest
58.50
61.00
-4.10%
Exceptional Items
3.00
20.80
-85.58%
Consolidate Net Profit
-54.00
-66.10
18.31%
Operating Profit Margin (Excl OI)
5.00%
-31.40%
3.64%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 7.74% vs 9.96% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 18.31% vs 86.59% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About ATI Physical Therapy, Inc. stock-summary
stock-summary
ATI Physical Therapy, Inc.
Pharmaceuticals & Biotechnology
Fortress Value Acquisition Corp II is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in any business operations. The Company has not generated any revenue.
Company Coordinates stock-summary
Company Details
1345 Avenue Of The Americas, 45Th Floor , NEW YORK NY : 10105
stock-summary
Tel: 1 212 7986100
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."